# Effect of Renin Angiotensin System Blockade on the Fas Antigen (CD95) and Asymmetric Dimethylarginine (ADMA) Levels in Type-2 Diabetic Patients With Proteinuria

> **NCT00893425** · PHASE4 · COMPLETED · sponsor: **Gulhane School of Medicine** · enrollment: 78 (actual)

## Conditions studied

- Proteinuria
- Diabetic Nephropathy
- Chronic Kidney Disease

## Interventions

- **DRUG:** ramipril

## Key facts

- **NCT ID:** NCT00893425
- **Lead sponsor:** Gulhane School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2009-03
- **Final completion:** 2009-04
- **Target enrollment:** 78 (ACTUAL)
- **Last updated:** 2009-06-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00893425

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00893425, "Effect of Renin Angiotensin System Blockade on the Fas Antigen (CD95) and Asymmetric Dimethylarginine (ADMA) Levels in Type-2 Diabetic Patients With Proteinuria". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00893425. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*